| HOME >> BIOLOGY >> TECHNOLOGY |
CINCINNATI, April 20 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced that it will not meet analyst expectations for the first quarter of 2009. The shortfall is due to the impact of unprecedented biopharmaceutical industry conditions, which are resulting in longer delays in the signing of contracts on existing awards, fewer new requests for proposals and an increase in contract cancellations and delays. The Company now expects net service revenues for the first quarter of 2009 to be well below the market consensus of approximately $121 million.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO )
The Company will host a conference call Tuesday, April 21, at 8:30 a.m. Eastern Time.
Conference Call and Webcast Details.
Conference Call Details:
Dial in: 866-834-5752 (United States and Canada)
706-643-4051 (Outside North America)
Replay: 706-645-9291
Conference ID Number 95120646
Webcast:
The call will be broadcast live over the Internet and can be accessed at www.kendle.com or http://www.videonewswire.com/event.asp?id=57853. The webcast will be archived at www.kendle.com (click on "Investors" shortly after the call. The conference call and archived webcast will remain available until 5 p.m. Eastern Time on May 21, 2009.
| SOURCE Kendle International Inc. Copyright©2009 PR Newswire. All rights reserved |